Events
Oyster Point Pharma, Inc. announced that Jeffrey Nau, PhD, MMS, President and CEO, is scheduled to present at the 31st Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2019 at 3:30 p.m. Eastern Time at the Lotte New York Palace in New York, NY.
HOOKIPA Pharma Inc. announced that HOOKIPA’s management team will present and host one-on-one meetings at Piper Jaffray 31st Annual Healthcare Conference, taking place December 3-5, 2019 in New York
Fulgent Genetics, Inc. announced that its Chairman and Chief Executive Officer Ming Hsieh, Chief Financial Officer Paul Kim, and Vice President of Commercial Operations Brandon Perthuis are scheduled to participate in the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at the Lotte New York Palace Hotel in New York, New York.
Neuronetics, Inc. announced that Chris Thatcher, President and Chief Executive Officer, and Steve Furlong, Chief Financial Officer, will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York, NY on Thursday, December 5, 2019.
Plus Therapeutics, Inc. announced that it will be participating at the upcoming 12th annual LD Micro Main Event.
Verrica Pharmaceuticals Inc. announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the Piper Jaffray 31st Annual Healthcare Conference in New York, NY on Tuesday, December 3, 2019 at 11:00 a.m. ET.
Veloxis to Host Conference Call Following Asahi Kasei Group’s Announcement of a Recommended Conditional Voluntary Public Offer for Veloxis
BONE THERAPEUTICS informs its shareholders and holders of warrants and convertible bonds of the Company that an extraordinary general shareholder meeting will be held on Thursday 12 December 2019 at 10am CET, at the Company’s registered offices, rue Auguste Piccard 37, 6041 Gosselies, Belgium.
BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced that it will host an investor breakfast meeting on Thursday, December 5, 2019 at the Convene Conference Center near Grand Central Terminal in New York, N.Y.
Alimera Sciences, Inc. announces that Rick Eiswirth, President and Chief Executive Officer of Alimera, will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York City on December 3, 2019.
PRESS RELEASES